Bizarre Patents
Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8182617 | Nitrogen alloyed stainless steel and process The present invention comprises the nitrogen alloying of stainless steel with a gaseous nitrogen compound such as nitrogen gas (N2), or ammonia (NH3) at high temperature wherein the reaction pressure is lowered. A base powder with properties si... | 05/22/2012 |
| D651301 | Air fragrance effector device | 12/27/2011 |
| 8076373 | Method for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite The present invention provides a method for treating wounds and diseases in mammals, caused by mammalian cells involved in an inflammatory response, by altering indigenous in vivo levels of peroxynitrous acid, and salts thereof. The method comprises contacting the m... | 12/13/2011 |
| 8053458 | Dipyrazole compounds and their use as central nervous system agents The present invention is directed to dipyrazole compounds of formula I and their pharmaceutically acceptable salts, stereoisomers, tautomers, or solvates thereof. Novel compounds include those of formula I. The compounds of t... | 11/08/2011 |
| 7629376 | 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase I The present invention discloses and claims compounds of formula (I) and formula (II) as inhibitors of human casein kinase Iε, and methods of using the compounds of formula (I) and formula (II) for treating central nervous ... | 12/08/2009 |
| 7576109 | 1,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereof The present invention is directed to 1,3,4-oxadiazolones, compounds of formula I and their pharmaceutically acceptable salts stereoisomers, tautomers, or solvates thereof. Novel compounds include those of formula I, in which radicals are as defined herein. | 08/18/2009 |
| 7563888 | Process for the preparation of diphenyl azetidinone derivatives The present invention is a process for the preparation of diphenylazetidinone derivatives of the formula (I) or forms thereof comprising the substituents X, R1 and/or R2 as defined herein. More specifically, the invention comprises methods for ... | 07/21/2009 |
| 7544809 | Method for the preparation of oxazoles by condensing aromatic aldehydes with α-ketoximes to form n-oxides and reacting same with activated acid derivatives The present invention is comprised of improved methods in the preparation of oxazoles which results in higher yields with less impurities and contaminants. Oxazoles constitute valuable intermediates in the synthesis of pharmaceutically active substances such as, for... | 06/09/2009 |
| 7538233 | Coumarins as iNOS inhibitors The present invention relates to coumarins of the formula (I): that are useful as inhibitors of nitric oxide synthase. Pharmaceutical compositions and methods of using these compounds as inhibitors of nitric oxide synthase ... | 05/26/2009 |
| 7538131 | 2-{-3-′2-(phenyl)-oxazol-4-ylmethoxymethyl-cyclohexylmethoxy}-propionic acid derivatives useful as peroxisome proliferator-activated receptor (PPAR) ligands for the treatment of hyperlipidemia and diabetes The present invention comprises compounds and compositions for the treatment of metabolic disorders and more particularly, those insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistance and the like comprising acetic acid... | 05/26/2009 |
| 7538106 | Application of 2-cyano-10- (2-methyl-3- (methylamino)- propyl) phenothiazine or a pharmaceutically acceptable salt as medicament The present invention relates to the application of 2-cyano-10-(2-methyl-3-(methylamino)-propyl)phenothiazine or a pharmaceutically acceptable salt thereof to produce a medicament intended for the treatment of sleep disorders, anxiety disorders, mood disorders, mixe... | 05/26/2009 |
| 7524887 | 2-amino-1,3-propanediol compounds for the treatment of acute pain The present invention relates to a method for the prophylaxis or treatment of pain using compounds of formula I, in which R, R2, R3, R4 and R5 have the meanings indicated in the specification. ... | 04/28/2009 |
| 7524838 | Pyrazolyl derivatives, preparation process and intermediates of this process as medicinal products and pharmaceutical compositions containing them The present invention relates to the novel derivatives of formula (I) in which A is, if it is present, a (C1-C6) alkyl, a (C3-C6) alkenyl, a (C3-C6) alkynyl, a (C3-C7) cycloalkyl or a (C5-C7) cycloalkenyl, R1 is an NR6R7, (C4... | 04/28/2009 |
| 7521449 | 4-arylmorpholin-3-one derivatives, their preparation and therapeutic use thereof The invention relates to compounds corresponding to formula (I): in which: Ar represents a mono- or disubstituted phenyl; R1 represents an unsubstituted or subs... | 04/21/2009 |
| 7488746 | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis Substituted thiophenes, processes for their preparation, their use as medicament or diagnostic agent. The substituted thiophene derivatives have the following backbone structure: Medicaments comprising compounds of this typ... | 02/10/2009 |
| 7488818 | Method for producing 1,4-diphenyl azetidinone derivatives The present invention is directed to the preparation of novel compounds useful in the treatment of hyperlipidemia, arteriosclerosis, hypercholesterolemia, and other related metabolic disorders. More specifically, the present invention is a novel process for the prep... | 02/10/2009 |
| 7482346 | Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors The present invention comprises alkylpiperazine- and alkylhomopiperazine carboxylates and their derivatives, methods for their preparation and the therapeutic use thereof as fatty acid amido hydrolase (FAAH) enzyme inhibitors. These derivatives exert various pharmac... | 01/27/2009 |
| 7453009 | Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use Disclosed are novel compound of formula I, As defined herein and their use as pharmaceutically active compounds for reducing blood glucose, and/or treating one or more of type II diabetes, disturbances of lipid and carbohyd... | 11/18/2008 |
| 7453000 | Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof The invention relates to compounds of formula (I), where the groups have the meanings set forth herein and the physiologically-acceptable salts thereof. The compounds are suitable as medicaments for lowering blood sugar levels and for prevention and treatment of dia... | 11/18/2008 |
| 7442717 | Substituted 2-aminoimidazoles, process for their preparation, their use as medicament or diagnostic aid Novel substituted 2-aminoimidazoles of formula I, process for their preparation, their use as medicament or diagnostic aid, and medicament containing them. The compounds of this type are useful in the prevention or treatment of various disorders and can be employed ... | 10/28/2008 |
| 7402672 | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon The present invention discloses and claims compounds of formula (I) as inhibitors of human casein kinase IF, and methods of using said compounds of formula (I) for treating central nervous system diseases and disorders incl... | 07/22/2008 |
| 7393867 | Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I The present invention discloses and claims compounds of formula (I) and formula (II), as inhibitors of human casein kinase Iε and methods for using said compounds for treating central nervous system diseases and disorders ... | 07/01/2008 |
| 7317033 | Substituted thiophenes: compositions, processes of making, and uses in disease treatment and diagnosis Substituted thiophenes, processes for their preparation, their use as medicament or diagnostic agent. The substituted thiophene derivatives have the following backbone structure: Medicaments comprising compounds ... | 01/08/2008 |
| 7259177 | Cycloalkylmethoxy-substituted acetic acid derivatives, processes for their preparation and their use as pharmaceuticals Provided herein are novel compounds of formula I below: in which the radicals are as defined, their physiologically acceptable salts, processes for their preparation, as well as methods of treating and/or prevent... | 08/21/2007 |
| 7241775 | Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines Substituted 4-phenyltetrahydroisoquinolines of formula I, process for their preparation, their use as a medicament and medicaments containing them. The compounds of formula I can be used, among other uses, in the e... | 07/10/2007 |
| 7122578 | Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration A method for treating the disease state in mammals caused by mammalian cells involved in the inflammatory response is disclosed. Mammalian cells participating in the inflammatory response are contacted with an inflammatory suppressor selected from the group consisti... | 10/17/2006 |
| 6770295 | Therapeutic formulation for administering tolterodine with controlled release The present invention is drawn to a method of treating an unstable or overactive urinary bladder by treating the patient with tolterodine or a tolterodine-related compound, or pharmaceutically acceptable salt thereof, with a controlled release formulation that maint... | 08/03/2004 |
| 6737410 | Inhibitors of protein farnesyl transferase The present invention provides compounds having the structure represented by Formula I: and methods of treating cancer, restenosis, atherosclerosis, or psoriasis or preventing restenosis, and a pharmaceutical composition... | 05/18/2004 |
| 6630162 | Pharmaceutical formulation and its use The invention relates to a pharmaceutical formulation containing tolterodine or a tolterodine-related compound, or a pharmacologically acceptable salt thereof, as active ingredient, in which the formulation exhibits a controlled in vitro release of the ac... | 10/07/2003 |
| 6615844 | Hair thinning measurement device A self-analysis hair density measuring device comprises a housing body with a calibrated gauge element movably affixed to one side of the housing body. There are at least two or preferably three movable pronged tines extending from within the proximal end... | 09/09/2003 |
| 6253771 | Hair thinning measurement device A comb-like device is useful in the measurement of hair thickness and density in order to determine the extent and/or degree of hair loss or thinning as well as hair regeneration if undergoing treatment therefore. The comb section or teeth are modified in... | 07/03/2001 |
| 6146596 | Soil remediation apparatus with safeguard system The present invention is an improved apparatus and method for its use in the decontamination and remediation of soils laden with organic hydrocarbons and toxic inorganic compounds. The soil to be treated is placed in a soil treatment tray which is subsequ... | 11/14/2000 |
| 6121222 | Anionic surfactants having multiple hydrophobic and hydrophilic groups A novel class of anionic surfactants with improved surfact active properties is comprised of two hydrophilic and two hydrophobic groups represented by the formula: ##STR1## The surfactants exhibit unusually low critical micelle concentration (cmc) ... | 09/19/2000 |
| 6083488 | Barrier to plaque formation A denture cleansing agent containing a film forming material for preventing plaque formation. The denture cleansing agent may be a denture cleanser tablet, and the film forming material may be a polyoxyethylene oxide/vinyl acetate copolymer.... | 07/04/2000 |
| 5952290 | Anionic gemini surfactants and methods for their preparation The present invention comprises a new, improved class of anionic gemini surfactants consisting of two hydrophilic groups and two hydrophobic moieties joined by a bridge that possess improved surfactant functionalities yet may be characterized as mild for ... | 09/14/1999 |
| 5952291 | Process for the preparation of high purity imidazoline based amphoacetate surfactants Imadazoline-based amphoacetates of higher purity, containing essentially negligible amounts of unalkylated amido amines, lower amounts of glycolic acid salts and monochloroacetate salts, superior to currently available conventional amphoacetates, are prov... | 09/14/1999 |
| 5945393 | Nonionic gemini surfactants Novel nonionic gemini surfactants are extremely effective emulsifiers for oil-in-water emulsions that provide improved detergency at even low concentration levels. The surfactants are characterized by the formula: ##STR1## wherein R1 is in... | 08/31/1999 |
| 5902110 | Bone regeneration A method for reducing bone resorption at tooth extraction sites by topically applying a prostaglandin inhibitor, such as a non-steroidal anti-inflammatory drug (NSAID) to the affected area. The preferred NSAID is ketoprofen. The composition may also inclu... | 05/11/1999 |
| 5900397 | Nonylphenol nonionic gemini surfactants Novel nonylphenol nonionic gemini surfactants are extremely effective emulsifiers for oil-in-water emulsions that provide improved detergency at even low concentration levels and are characterized by the formula: ##STR1## wherein R and R1 ... | 05/04/1999 |
| 5882636 | Phthalate free nail polish enamel composition A phthalate-free long-lasting nail polish enamel composition consisting essentially of a film-forming agent, solvents, one or more colorants, one or more suspending agents, adhesion promoters and plasticizers selected from the group consisting essentially... | 03/16/1999 |
